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Summary
Disturbed nitric oxide (NO) synthesis leads to development of endothelial
dysfunction that plays a significant role in the pathogenesis of arterial hypertension.
The presence of various compounds of haemoglobin with NO can affect
haemoglobin-oxygen affinity of the whole blood. Methaemoglobin and
S-nitrosohaemoglobin increase it, whereas nitrosyl-haemoglobin decreases. The
aim of this study was to investigate the blood oxygen transport indices and to assess
the endothelial function in patients with arterial hypertension. The patients with
mild hypertension had a 4Æ47% increased actual p50 (the blood pO2 corresponding
to its 50% oxygen saturation) (P<0Æ05), a diminished pO2 (P<0Æ05), and a raised
pCO2 (P<0Æ01) as compared with the controls. The patients with severe
hypertension had decreased pO2 and pH, and actual p50 was reduced by 3Æ03%
(P<0Æ05), which reflects a more pronounced oxyhaemoglobin dissociation curve
shift leftwards. These changes can be assessed as a blood oxygen transport
decompensation that enhanced tissue hypoxia. The results of our studies indicate
that the endothelial dysfunction in patients with arterial hypertension leads to
significant impairments in blood oxygen transport indices. The endothelium may be
involved in development of the above blood oxygen transport impairments, since
only sufficient amounts of NO maintain a normal blood flow and oxygen transport
to tissues. The endothelial dysfunction leads to a disturbed production of different
haemoglobin NO derivatives, which not only affects NO release at different sites of
the arterial bed, but also haemoglobin-oxygen affinity and optimal blood
oxygenation and deoxygenation in capillaries. These data support the notion that
endothelial dysfunction may alter haemoglobin-oxygen affinity and tissue oxygen
supply in vivo. Alternation of haemoglobin-oxygen supply may be involved in the
pathogenesis of hypertension.
Introduction
The endothelium plays an important role in modelling of
vascular tone and releasing vasodilative and vasoconstrictive
substances. Nitric oxide (NO) released by endothelial cells
causes relaxation of a vascular smooth muscle, inhibits platelets
adhesion and aggregation and depresses smooth muscle cells
proliferation (Luscher & Barton, 1997; Marin & Rodriguez-
Martinez, 1997; Vanhoutte, 1997). The disturbed NO synthesis
results in development of endothelial dysfunction (impaired
endothelial metabolism of the L-arginine-NO pathway) (Kelm &
Rath, 2001), which plays a significant role in the pathogenesis
of arterial hypertension (Panza et al., 1993; Taddei et al., 2000).
The impaired NO bioavailability is an important factor in
development of arterial hypertension. Experimental animal
models of arterial hypertension showed an increase in expres-
sion of endothelial NO synthase isoform and its activity at the
early stages and their decrease at the late ones (Kelm et al.,
1995). The patients experienced a decrease in metabolism of
NO donors and sensitivity of muscular elements to this agent.
The principal mechanisms of impairment in L-arginine-NO
pathway metabolism are the absence of the initial L-arginine
substrates or cofactors, diminished expression of endothelial NO
synthase and a raised level of NO endogenous inhibitors, as well
as NO inactivation by free radicals (O2
), OH*) (Kelm & Rath,
2001).
The endothelial function is closely related to tissue oxygen
transport. Oxygen is known to be an important factor governing
NO synthase activity (Cannon, 1998). NO maintains the blood
flow level, thus providing oxygen supply to tissues. A
Clin Physiol Funct Imaging (2004) 24, pp205–211
 2004 Blackwell Publishing Ltd • Clinical Physiology and Functional Imaging 24, 4, 205–211 205
Ре
по
зи
то
ри
й Г
рГ
М
У
disturbance in endothelial NO synthase function stipulates to a
great extent the loss of control over vascular tone, resulting in a
reduction of an adequate providing of tissue requirements for
oxygen. Recently, the NO and haemoglobin interaction has been
actively studied. Three main NO derivatives of haemoglobin
have been known: nitrosylhaemoglobin (HbFe2+ NO), nitros-
ohaemoglobin (SNO–Hb) and methaemoglobin. In the HbFe2+
NO molecule, NO is related to haeme Fe2+ sites, whereas SNO–
Hb is the result of the interaction of NO with cysteine (93) on
the b-globine chain (Stamler et al., 1997; Gladwin et al., 2002).
The presence of different haemoglobin compounds with NO
can affect the haemoglobin-oxygen affinity in the whole blood
in different ways. Methaemoglobin and SNO–Hb increase it,
whereas HbFe2+ NO decreases, respectively. Their effect on the
formation of blood oxygen function indices can be of primary
importance for respiratory metabolism (Zinchuk & Borisiuk,
1998; Zinchuk & Dorokhina, 2002).
The aim of this study was to investigate the blood oxygen
transport indices and to assess the endothelial function in
patients with arterial hypertension.
Methods
The study population included 52 patients with arterial
hypertension that were examined and treated in our clinic.
Patients with diabetes mellitus, acute infectious diseases, kidney
insufficiency, with atrial fibrilation, chronic congestive heart
failure and acute disturbance of cerebral circulation were
excluded from the sample. The possibility of secondary
hypertension causes was excluded by standard clinical and
laboratory tests. No subjects had evidence of hypercholester-
olemia, none of them were smokers.
The clinical characteristics of the study population are
provided in Table 1. The control group included 24 healthy
volunteers (10 women and 14 men) with the mean age of
37Æ9 years (24–52). Normal blood pressure was defined as
systolic blood pressure <130 mmHg and diastolic blood
pressure <85 mmHg. The patients were divided into three
groups, depending on the degree of arterial hypertension.
Arterial hypertension was diagnosed in accordance with the
WHO/ISH criteria approved in 1999. Mild hypertension
(arterial hypertension I degree) was defined as a systolic blood
pressure >140 mmHg and/or a diastolic blood pressure
>90 mmHg. Moderate hypertension (arterial hypertension II
degree) was defined as a systolic blood pressure >160 mmHg
and/or a diastolic blood pressure >100 mmHg. Severe
hypertension (arterial hypertension III degree) was defined as
a systolic blood pressure >180 mmHg and/or a diastolic blood
pressure >110 mmHg [European Society of Hypertension
(2003)– European Society of Cardiology guidelines for the
management of arterial hypertension]. The first group included
17 patients with mild hypertension (four women and 13 men)
with the mean age of 25Æ6 years (18–53) and the disease
duration of 3Æ3 ± 0Æ7 years. The second group included 20
patients with moderate hypertension (nine women and 11 men)
the mean age of 42Æ0 years (23–65) and the disease duration of
9Æ4 ± 4Æ8 years. The third group included 15 severe hyperten-
sive patients (eight women and seven men), the mean age of
52Æ5 (38–60) and the disease duration of 10Æ8 + 1Æ0 years.
Within 2 weeks the patients with moderate and severe
hypertension were treated with the following drugs: the
angiotensin-converting enzyme inhibitor – Enalapril maleate
(1-[N-1-carboxy-3-phenylpropyl]-L-alanyl]-L-prolin-1¢ ethyl
ether) and the beta-adrenoblocker – atenolol [4-(Oxy-3-izopro-
pylaminopropoxy) phenyl-acetamide]. The patients with mild
hypertension were not treated with drugs.
A venous blood sample was collected in heparinized syringes.
The protocols of the studies were approved by the Ethics
Committee of Grodno State Medical University, and informed
consent was obtained from each participant. All the experimen-
tal procedures followed institutional guidelines. All the studies
were performed in the morning. The subjects fasted the
overnight for at least 12 h before the examination.
The level of the end NO metabolites, nitrite/nitrate, was
measured in blood plasma spectrophotometrically using the
Griess method (Moshage et al., 1995). The participants of the
investigation undertaken low nitrite and nitrate diet during
the study and 3–4 days before the studies. The subjects were
instructed to refrain from eating food rich nitrites and nitrates
(alcoholic beverages, caviar, roots, cured meat and canned
vegetables, leafy vegetables) according to the recommends
(Wang et al., 1997).
The endothelial function was measured by strain-gauge
plethysmography. There is a high correlation between the
Table 1 Clinical characteristics of hypertensive patients and normotensive control subjects.
Controls Mild hypertension Moderate hypertension Severe hypertension
Number 24 17 20 15
Age (years) 37Æ9 ± 1Æ9 25Æ6 ± 2Æ5 42Æ0 ± 2Æ1 52Æ5 ± 1Æ23
Sex (male/female) 14/10 13/4 11/9 7/8
Duration of the disease (years) – 3Æ3 ± 0Æ7 9Æ4 ± 4Æ8 10Æ8 ± 1Æ0
Total cholesterol (mmol l)1) 4Æ90 ± 0Æ41 5Æ17 ± 0Æ31 5Æ42 ± 0Æ45 5Æ80 ± 0Æ34
Glucose (mmol l)1) 5Æ1 ± 0Æ6 5Æ4 ± 0Æ7 5Æ3 ± 0Æ5 5Æ4 ± 0Æ4
Creatinine (lmol l)1) 72Æ3 ± 4Æ2 73Æ5 ± 8Æ4 73Æ8 ± 5Æ6 76Æ2 ± 6Æ6
Systolic pressure (mmHg) 118Æ8 ± 1Æ22 153Æ8 ± 1Æ77 170Æ54 ± 2Æ08 194Æ7 ± 3Æ65
Diastolic pressure (mmHg) 74Æ7 ± 1Æ17 90Æ3 ± 1Æ79 102Æ3 ± 1Æ44 111Æ8 ± 3Æ66
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endothelial function evaluated by strain gauge plethysmography
and the brachial artery ultrasound (Irace et al., 2001) The
methods of assessment endothelium-dependent dilatation by
intraarterial infusion of acetylcholine are invasive. Instead of the
acetylcholine infusion we used reactive hyperaemia in the
assessment of resistance vessel endothelial function, which was
reported earlier as a non-invasive test (Higashi et al., 2001). The
measurements were carried out in a room with a constant
temperature of 22–24 C. First, the forearm blood flow was
measured at rest (after the patient had rested in supine position
for 20 min). Then we studied the endothelium-dependent and
endothelium-independent mechanisms (Celermajer et al., 1992).
The endothelium-dependent dilatation of peripheral arteries was
induced by reactive hyperaemia using a blood pressure cuff
placed around the arm and inflated to up 280 mmHg within
5 min. The changes in the forearm blood flow were estimated
after the removal of the cuff for 5 min. After the recovery of the
initial forearm blood flow, an endothelium-independent
response was studied, for which the patient intook sublingually
0Æ5 mg of nitroglycerine. The forearm blood flow was studied
before the nitroglycerine intake and within 15 min after it. The
forearm blood flow at the 90th second after the release of
occlusion and the forearm blood flow at the third minute after
the nitroglycerine intake were determined as a percentage change
relative to baseline measurements. The criterion for endothelial
dysfunction was a less than 10% increase of the forearm blood
flow after reactive hyperaemia.
The blood oxygen indices: blood pO2, pCO2, pH, the actual
excess of buffer bases, the standard excess of buffer bases, the
standard hydrocarbonate concentration and the concentration of
total carbon dioxide were measured using an ABL-330 Radio-
meter microgasoanalyzer (Copenhagen, Denmark). The haemo-
globin-oxygen affinity was determined according to the p50
index (the blood pO2 corresponding to its 50% oxygen
saturation) by the mixing method in the modification of Scheid
& Meyer (1978), the p50 standard was assessed under standard
conditions (pH ¼ 7Æ4; pCO2 ¼ 40 mmHg and T ¼ 37C),
whereas the p50 actual was calculated for the real values of
these factors. On the basis of the p50 values obtained, the Hill
equation was used to calculate the position of the oxyhaemo-
globin dissociation curve.
The above studies were carried out before and after the
2-week treatment.
Statistics. The results are presented as mean values ± SEM.
Statistical evaluation of the differences between the means was
made using the Student’s two-tailed unpaired t-test. Pearson’s
r coefficient was used to test the correlation. The differences
were considered statistically significant at a level of P<0Æ05.
Results
Our studies have shown that the blood plasma nitrite/nitrate
level in patients with mild hypertension did not differ from that
in healthy individuals (Table 2), whereas that in patients with
moderate hypertension was lower by 28Æ1% and that in severe
hypertension – by 32Æ7% as compared with healthy individuals.
According to the strain-gauge plethysmography data, the
endothelium-dependent vasodilatation was maintained only in
patients with mild hypertension (the increase of the forearm
blood flow for reactive hyperaemia did not differ from that in
healthy individuals) (Fig. 1). In patients with moderate hyper-
tension, it was lower as compared with healthy subjects and
patients with mild hypertension (increase of the forearm blood
flow for reactive hyperaemia was 17Æ09 ± 1Æ76%) In this
situation, the endothelial dysfunction was only in 23Æ8% of
patients with moderate hypertension (less than 10% increase of
the forearm blood flow). In patients with severe hypertension,
the forearm blood flow for reactive hyperaemia increased by
Table 2 Plasma level concentration of nitrite/
nitrate (lmol l)1) in patients with arterial
hypertension before and after treatment
(M ± m).
Index Control
Mild
hypertension
Moderate
hypertension
Severe
hypertension
n 24 17 20 15
Basal level 21Æ39 ± 1Æ07 19Æ13 ± 1Æ30 15Æ38 ± 0Æ65ab 13Æ24 ± 1Æ32ab
After treatment 18Æ81 ± 1Æ41c 16Æ26 ± 1Æ43
aSignificant differences from control group; bsignificant differences from mild hypertension;
csignificant differences after treatment.
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Figure 1 Severity-associated changes in forearm blood flow in patients
with arterial hypertension before and after treatment.
 Significant differences from control group (P<0,05);  Significant
differences from control group, (P<0.01); FBF, forearm blood flow;
NG, nitroglycerine.
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10Æ20 ± 1Æ63%. It was lower as compared with healthy
individuals and patients with moderate hypertension. The
endothelial dysfunction was in 73Æ3% of the cases. Endothe-
lium-independent vasodilatation did not differ in all the groups
(the forearm blood flow for sublingual nitroglycerine admin-
istration increased by more than 19%). A moderate positive
correlation was found between the nitrite/nitrate level and the
value for the forearm blood flow for reactive hyperaemia in
patients with arterial hypertension (r ¼ 0Æ47, P<0Æ01).
In patients with mild hypertension, the blood oxygen transport
indices did not differ from those in healthy individuals (Table 3).
As compared with controls, the patients with moderate hyper-
tension showed 4Æ47% increased p50 actual (P<0Æ05), p50
standard elevated by 4Æ48% (P<0Æ05), pO2 decreased (P<0Æ05)
and pCO2 rose. The decrease of the haemoglobin-oxygen affinity,
i.e. the shift of the real oxyhaemoglobin dissociation curve
rightwards (Fig. 2) in these patients should be estimated as a
compensatory reaction for hypoxia. In patients with severe
hypertension p50 actual decreased by 3Æ3% (P<0Æ05), which
reflects a more pronounced shift of the real oxyhaemoglobin
dissociation curve leftwards (Fig. 2), p50 standard was decreased
by 5Æ7% (P<0Æ05) compared with the healthy individuals. The pH
value decreased to 7Æ3 ± 0Æ01 (P<0Æ05). These changes should be
considered as a decompensation of blood oxygen function that
increased tissue hypoxia. A moderate positive correlation was
revealed between the p50 standard and the blood plasma nitrite/
nitrate level (r ¼ 0Æ435, P<0Æ01).
After the combined treatment, the patients with moderate
hypertension had an increased nitrite/nitrate level as compared
with the initial one (Table 2). The forearm blood flow for
reactive hyperaemia rose insignificantly in this group. The
treatment of patients with moderate hypertension increased the
haemoglobin-oxygen affinity [p50 standard decreased by 5Æ2%
(P<0Æ05)]. In patients with severe hypertension, the nitrite/
nitrate level and the forearm blood flow for reactive hyperaemia
did not change significantly after the treatment. However, our
treatment decreased the haemoglobin-oxygen affinity [p50
standard elevated by 6Æ1% as compared with the initial one
(P<0Æ05)], which favoured improvement of tissue oxygenation.
The intake of angiotensin converting inhibitors, beta-adreno-
blockers for 2 weeks somewhat improved NO synthesis, but only
in patients with moderate hypertension. In patients with severe
hypertension, this treatment was insufficient to correct the
disturbances found, which was observed by other authors, too.
Some authors (Higashi et al., 2002) also noted improvement of
endothelial function after the application of the angiotensin
converting inhibitor at the early stages of hypertension and their
inefficiency in severe hypertension. Another scientists (Taddei
et al., 2001) showed inefficiency of atenolol in recovering of
endothelial function in patients with hypertension.
Discussion
Thus, judging by the level of the end products of NO metabolism
(nitrates and nitrites), a decreased NO synthesis is observed even Ta
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in patients with moderate hypertension, and it progressively
worsens as the disease aggravates. The decreased blood plasma
nitrite/nitrate level is observed depending on the severity of
hypertension and endothelial dysfunction. Earlier Node et al.
(1997a) have found lower nitrite/nitrate levels in hypertensive
patients, but he did not studied patients with a different degree of
the disease. The measurement of nitrite and nitrate ions in plasma
can be used as an index of endogenous formation of NO
(Jungersten et al., 1996; Vassalle et al., 2002). However, this
method has some restrictions (Ellis et al., 1998). Nitric oxide,
which subsequently appears as nitrites and nitrates, originates
from different types of NO synthase and from non-enzymatic
reactions. Nitrite and nitrate also come from exogenous sources
such as food and gastrointestinal microorganisms (Ishibashi et al.,
1999). There is a strong correlation between the serum nitrite/
nitrate level and creatinine concentration (Mackenzier et al.,
1996). Patients in our study had not acute infectious diseases and
kidney insufficiency. All the subjects had a normal serum
creatinine concentration (Table 1). We have taken into account
the influence of the diet, as was mentioned above.
The regulatory function of the endothelium is altered by
different cardiovascular risk factors or disorders (Drexler &
Hornig, 1999). Studies of serum nitrate/nitrite levels in healthy
persons of different age demonstrated that NO synthesis or
secretion are reduced with age (Toprakci et al., 2000). Decreased
plasma nitrite/nitrate level was found in smoking young adults
(Node et al., 1997b; Vassalle et al., 2002). Even smoking a single
cigarette temporarily decreases plasma nitrate and nitrite
concentration (Tsuchiya et al., 2002). Some authors have
demonstrated reduced plasma nitrite/nitrate level in subjects
with primary hypercholesterolemia without other risk factors
and atherosclerosis (Tanaka et al., 1997; Sardo et al., 2002). In
our study, all smokers and persons with hypercholesterolemia
were excluded.
The influence of age on the changes of haemoglobin-oxygen
affinity is strongly pronounced in young persons. In males
haemoglobin-oxygen affinity increased with ageing (Humpler
et al., 1989), but in our study, we investigated a middle-age
persons. The changes of haemoglobin-oxygen affinity are feebly
marked in this age group.
The changes in L-arginine-NO pathway activity and the
functional endothelial state on the whole affect the blood
oxygen transport indices. The biological function of NO
derivatives of haemoglobin is unclear in many respects.
Haemoglobin is capable of fulfilling the function of NO storage
in the microcirculatory network. In the vascular network, the
nitrosothiols produced in NO-mediated thiol nitrosylation play
an important role in NO transport, storage and metabolism
(Jourd’Heuil et al., 2000). The effect of SNO–Hb population on
NO supply to tissues can be very pronounced since the
mechanism of its release from this haemoglobin compound is
very sensitive to deoxygenation and is especially manifested in
considerable pO2 changing (in hypoxic area) (Patel et al., 1999).
Sequestrating NO in terminal arterioles and capillaries, eryth-
rocytes reduce its participation in vasodilatation, thus forming
blood oxygen transport indices. The oxygen-dependent nature
of the HbFe2+ NO and SNO–Hb equilibrium provides the
correspondence of the blood flow and its requirements, i.e. an
optimum balance between hypoxic vasodilatation and hyperoxic
vasoconstriction (Stamler et al., 1997). There are mechanisms
that accelerate NO release from HbFe2+ NO at low pO2 at the
sacrifice of the haemoglobin transition to the T-state for which
the dissociation rate constant is two orders higher. These
mechanisms are even more enhanced by heterotropic efectors
(H+, 2,3 diphosphoglycerate) (Colleta et al., 1999).
By inhaling NO in endothelial dysfunction it may be possible
to maintain the normal vascular function due to production of
different forms of NO derivatives of haemoglobin and NO release
by them (Cannon et al., 2001). Methaemoglobin and SNO–Hb
have higher oxygen affinity, whereas HbFe2+ NO – decreased
one. The p50 value for SNO–Hb outside an erythrocyte is equal
to 10 mmHg (Bonaventura et al., 1999), whereas that for a SNO–
Hb solution – (with 30% nitrosylation of 93 cysteine) – to
4Æ3 ± 0Æ27 mmHg (Patel et al., 1999) and that for HbFe2+ NO –
to 39Æ6 ± 1Æ5 mmHg (Kosaka & Seiyama, 1996). The blood
SNO–Hb and HbFe2+ NO concentrations are such that either of
these derivatives has on the average 1000 tetramers of haemo-
globin, and this makes their effects on blood oxygen-binding
properties relatively negligible under general conditions (Jia
et al., 1996; Yonetani et al., 1998), but at NO concentrations
above physiological conditions (at low pH, on addition of
inosytolhexaphosphate, at low temperature) this is quite poss-
ible. Their effect on the modulation of the blood oxygen-binding
properties is manifested at high concentrations (5 and above%),
and this may be important for gas exchange properties in
capillaries (Zinchuk, 1999; Zinchuk & Dorokhina, 2002).
We should take into consideration the endothelial hetero-
geneity according to the NO-producing function along the
vascular channel. The immunohistological studies show that
endothelial NO synthase expression is decreased in different
regions of the vascular system as the diameter diminishes: it is
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Figure 2 Actual oxyhemoglobin dissociation curves: control (h),
moderate hypertension (D), severy hypertension ()) before treatment.
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the highest in arterioles and much lower in veins (Kelm & Rath,
2001). The basal NO synthesis level is higher in arteries as
compared to veins, and, judging by the nitrite/nitrate value, it is
much higher than in venous blood (45Æ1 ± 17Æ7 compared with
22Æ5 ± 8Æ5 lmol) (Cicinelli et al., 1999). Important in the NO
effect on haemoglobin-oxygen affinity is blood volume in
different cardiovascular system regions. Terminal arterioles and
capillaries occupy a greater part of the total vascular system,
whereas the volume of blood contained in them is much smaller
(Hinsberg, 2001), and, respectively, the relative blood volume
per a unit of arteriole and capillary square in this region will be
the greatest. This suggests higher contents of NO and its
derivatives at the microcirculatory site of the vascular bed (100
times and over) and, correspondingly, its even greater content
interacting with haemoglobin. The importance of NO binding
with haemoglobin haemes is not only in its immediate effect on
the functional behaviour of NO-carrying molecules, but also on
the haemoglobin population at this site of the vascular system.
As for microcirculation, this can be extremely important for
modifying NO oxygen-binding properties and, in the long run,
for tissue oxygenation.
Thus, the results of our studies show that severe disturbances
in blood oxygen function indices are observed in hypertensive
patients with endothelial dysfunction. Endothelium can partici-
pate in forming the above disturbances, as only NO produced in
sufficient amounts can maintain a normal blood flow and
oxygen transport to tissues. In endothelial dysfunction, produc-
tion of different NO derivatives of haemoglobin is disturbed,
which does not only affect the NO release by them at different
sites of the vascular bed, but also the haemoglobin-oxygen
affinity, and, respectively the optimum proceeding of blood
oxygenation in capillaries of lesser circulation and its deoxy-
genation in capillaries of greater circulation. These data support
the notion that endothelial dysfunction may alter haemoglobin-
oxygen affinity and tissue oxygen supply in vivo. Alternation of
haemoglobin-oxygen supply may be involved in the pathogen-
esis of hypertension.
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